Moderna, Inc.
Close on Nov 19, 2026Market cap $79.58BP/E –Yield –
Moderna Minimum unconditional purchase obligations by Year
Minimum unconditional purchase obligations — Clinical & R&D service contracts ($M) ($M)
Moderna Minimum unconditional purchase obligations: $1,000M in FY2025, up 323.7% from a year earlier.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-20) ↗
Reported in Form 10-K Note 11 (Commitments and Contingencies).
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Minimum unconditional purchase obligations — Clinical & R&D service contracts ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,000 | +323.7% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 236 | -9.6% | Form 10-K (filed 2025-02-21) ↗ |
| FY2023 | Dec 31, 2023 | 261 | +47.5% | Form 10-K (filed 2024-02-23) ↗ |
| FY2022 | Dec 31, 2022 | 177 | +98.9% | Form 10-K (filed 2023-02-24) ↗ |
| FY2021 | Dec 31, 2021 | 89 | +229.6% | Form 10-K (filed 2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | 27 | – | Form 10-K (filed 2021-02-26) ↗ |
Cite this data
StockData. (2026). Moderna Minimum unconditional purchase obligations ($M), annual FY2020–FY2025 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/purchase-commit-clinical
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.
See a number that looks wrong?